Drug Formulation & Bioavailability Congress September 05-07, 2016 Beijing, China

ConferenceSeries Ltd  genially invites all the participants across the sphere to attend our prestigious conference “Drug Formulation & Bioavailability Congress” scheduled during September 05-07, 2016 Beijing, China. Drug Formulation 2016 is a outstanding event which brings together a unique and International mix of large & medium Pharmaceutical industries/companies, leading top universities, research institutions building the conference a perfect podium to share their experience, foster collaborations across industry and academia, to evaluate emerging technologies across the globe.

 Track 1: Preformulation Studies

Preformulation is described as a phase of the research & development process where the preformulation scientist characterises the Physico-chemical and mechanical properties of an Active Pharmaceutical ingredient, to develop stable, effective and safe dosage form. Formulation is a process in which several chemical substances, which includes the active drug, are mixed to produce a medicinal product. Pharmaceutical formulation plays a very vital role in drug delivery to the desired target area in the body.  

Relevant Conferences:

9^th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4^th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4^th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2^nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK;  Novel Immuno-therapeutics Summit January 25-26, 2016 San Diego, US; ICDDT-7^th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit, February 24-25, 2016 Nairobi, Kenya; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 2: Formulation

Formulation is the process where different chemical substances including the drug product which are combined to produce a medicinal product. There are various anatomical routes which are thought them as medical drugs that can be administered directly into the human body. The selection process of the route depends upon three factors which are: the effect desired type of disease & finally the type of product. Oral route is the oldest route which has been used for conventional & the novel drug delivery administration. Parenteral route, these are the routes which include intramuscular, intravenous, intra-arterial and the subcutaneous route. Transdermal route is the medical treatment that will apply on surfaces of the body such as skin/mucous membrane. Inhalation route, is the type of medical treatment application route where the medical treatment will directly reach the lungs, through this way this route is considered as route of choice to avoid systemic effect and increase the bioavailability of the drug in the system.

Relevant Conferences:

6^th Annual American Drug Delivery & Formulation Summit June 12-14, 2016, Hilton San Diego Resort & spa;   5th Drug Formulation, Solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel 210 West Rittenhouse Square, Philadelphia, PA ;  18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London ;  2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK  ; 4th Annual Conference on European Pharma  Congress June 18-20, 2016 Berlin, Germany ;  2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016 Chicago, USA  ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 3: Drug Formulation Procedures

Pharmaceutical formulation Procedures will take a number of trials and screening at various stages so as to generate potent drug for the treatment of several diseases. After going through the different stages, the candidate found most suitable drug for the purpose is selected. Drug Formulation 2016 China is going to cover wide and interesting topics like this.

Relevant Conferences:

6^th annual American Drug Delivery & Formulation Summit June 12-14, 2016|Hilton San Diego Resort & spa; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 , Philadelphia, PA ;  18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London ;  2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK  ; 4th Annual Conference on European Pharma Congress June 18-20, 2016 Berlin, Germany ;  2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016, Chicago, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA ; Annual Congress on Rare Diseases Orphan Drugs May 12-13, 2016 Chicago, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 4: Novel Drug Delivery System

The term drug delivery system was coined in the year 1970 to describe a series of technologies, used to develop finished drug products that were not immediate release. Drug release, absorption, distribution, and elimination process are to improve the product efficacy; safety, patient convenience and compliance are modified through drug delivery technologies. Oral route and parenteral route are the most common routes of drug delivery but in many conditions alternative drug delivery is favoured. Drug delivery system is another term for formulation.

Relevant Conferences:

International Conference on Drug Discovery and Designing, Feb 04-05, 2016, Melbourne ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery  Systems, March 07-09, 2016, Madrid, Spain ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE  ; 7th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Dusseldorf, Germany; 9^th World Drug Delivery Summit June 30- July 02, New Orleans, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016,Valencia, Spain ;5th Medicinal Chemistry & Computer Aided Drug Designing  Conference Dec 1-3, 2016 Chicago, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 5: Drug Evolution Process of IND, NDA & ANDA

Drug development is divided into types. The first type is Pre-clinical phase, usually takes 3 to 4 years to complete. If fruitful, this phase is followed by an appeal to the FDA as an Investigational New Drug (IND). After the approval by IND, the next stages are of clinical phases 1, 2, & 3, which require approximately 1-3 years for completion. Importantly, throughout the process of FDA, an investigator leading the clinical trials to communicate with each other so that safety is monitored. The manufacturer then files a New Drug Application (NDA) with the FDA for approval. This appeal can either be approved/ rejected; otherwise the Food and Drug Administration might request further study before making a quick decision. Following the acceptance, the FDA can also request the manufacturer to conduct additional post-marketing studies.  On average the entire process takes between 8 to 12 years.

Relevant Conferences:

International Conference on Drug Discovery and Designing, Feb 04-05, 2016, Melbourne ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery  Systems, March 07-09, 2016, Madrid, Spain ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE  ; 7th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Dusseldorf, Germany ; 9th World Drug Delivery Summit June 30- July 02, New Orleans, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016,Valencia, Spain ;5th Medicinal Chemistry & Computer Aided Drug Designing  Conference Dec 1-3, 2016 Chicago, USA; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 6: Shelf Life & Stability Studies

It involves in developing the preparation of drug which is both stable and acceptable form to the patient which is essential for drug product marketing approval. Stability studies are conducted at all stages of the drug development cycle for different purposes with ultimate goal of having a stable product on the market.  During the development process of drug formulation stability studies are conducted to support formulation development, safety & efficacy claims of investigational new drugs.  At registration, they are conducted to ascertain the quality and also the shelf-life of drug product in their intended packaging configuration. After approval, stability studies are conducted to ensure the quality of production & to support site or other changes to the product.

Relevant conference:

7th International Conference on Drug Discovery and Therapy,15th -18th February 2016, Dubai, UAE ; World Drug Safety Americas 2016, 20 - 21 April, Hilton DoubleTree, Magnificent Mile, Chicago ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 7: Drug Product Manufacturing         

Traditional and enhanced methods are not mutually exclusive. Today's competitive Pharmaceutical industry environment requires drug manufacturing that continuously strives to improve quality of the product while reducing production costs. So the drug product manufacturing track has been designed to focus on most advanced technology of manufacturing processes.

Relevant conference:

4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ;  Structure Based Drug Design Conference 2016, 21st – 24th February ,  San Diego, USA ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia ; 18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 8: Analytical Method Development and Validation

Analytical methods are validated to provide reliable data towards regulatory submissions. These methods are essential for several purposes, including testing of QC release, testing of stability samples, testing of reference materials and also to provide data towards support specifications. It provides a comprehensive coverage of method development & validation requirements to develop a pharmaceutical compound, at every stage of product development.

Relevant conference:

10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 4-7 April, 2016, Glasgow, UK ; 2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK ; 7th Annual Global Drug Delivery & Formulation Summit, 23-25 may, 2016 | Berlin, Germany ; 6th Annual American Drug Delivery & Formulation Summit, June 12-14, 2016 | Hilton San Diego Resort & spa ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 9: Biopharmaceutics Classification System                                                 

Biopharmaceutics Classification System divides compounds into 4 classes supported their porosity & solubility. This organization is highly beneficial in prophesying effects of outflow and then uptake of transporters on oral absorption, further based as on post absorption general stages following oral and endogenous dosing. The role of BCS & BDDCS in Drug Development is to characterize the medicinal product of these medicines could also be suitable for a bio waiver of in-vivo bioequivalence studies.

To improve efficiency of the drug development and also the review process by recommending a strategy for identifying superfluous clinical bioequivalence tests and a class of immediate-release (IR) solid oral dosage forms, where bioequivalence may be evaluated based on in-vitro dissolution tests. 

Relevant conference:

5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel , 210 West Rittenhouse Square, Philadelphia ; 2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK ; 24th -25th February 2016, Africa Pharmaceutical Summit, Safari Park Hotel, Nairobi, Kenya;  4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 10: Bioavailability Studies and Bioequivalence Studies

The Amount of a substance which becomes available to reach the target organ or systemic circulation to an organism's (body) for bio-activity when it get introduced through ingestion, inhalation, injection, or skin contact. The rate of bioavailability depends upon factors, such as the type of substance and composition of diet.

Relevant Conferences:

International Conference on Drug Formulation, Bioavailability and Pharmacological Sciences, Jan 25-26, 2016, Istanbul ; 5th Drug Formulation & Bioavailability, January 25 - 27, 2016, Boston, Massachusetts, USA; International Conference on Clinical Pharmacology and Drug Design, May 12-13, 2016, Amsterdam ; 3rd International Conference on Health Informatics and Technology June 27-29,2016, New Orleans, USA ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul ; 5th European Food Safety and Standards Conference, Oct 24-26, 2016,Valencia, Spain ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).    

Track 11: Factors Affecting Bioavailability

In pharmacology, bioavailability is a subdivision of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. There are many recent advances and factors affecting Bioavailability. It includes Absorption, metabolism and Food effect of Drugs. Physico-chemical factors first pass metabolism and Energy dependent efflux transporters are also discussed in in the Congress.

Relevant Conferences:

International Conference on Drug Formulation, Bioavailability and Pharmacy, Jan 18-19, 2016, London ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai ; 4th Annual Conferences on European Pharma Congress June 13-15, 2016 Berlin ; 9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA ; International Conference on Chemical and Food Engineering ,Oct 29-30, 2015,  Paris ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 12: Nutrient Bioavailability

The term Nutrient Bioavailability refers to the proportion of a nutrient that is absorbed from the diet and used for normal body functions. It includes enhancers of nutrient bioavailability, factors playing a critical role in absorption of Nutraceutical and herbal products. The role of BPDM nutrient bioavailability is discussed under this track.

Relevant Conferences:

International Conference on Drug Design, Development and Clinical Pharmacy, May 08-09, 2016, Dubai; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016,Dallas, USA ; 6th International Conference and Exhibition on Analytical & Bioanalytical Techniques  September 1-3, 2015 Valencia, Spain ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA;  2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 13: Advances in Bioavailability

Bioavailability (BA) is a part of pharmacology and a subcategory of ingestion and also a part of managed measurement of unaltered medication which achieves the systemic flow. It is one of the important pharmacokinetic properties of medications.

Relevant Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques March 17-18, 2016 London, UK;  International Conference on Pharmaceutical Drugs and Drug Developments, Mar 30-31, 2016, Istanbul ;International Conference on Clinical Pharmacology and Computer Aided Drug Development, Apr 08-09, 2016, Dubai ; International Conference on Pharmaceutical Regulatory Affairs, April 29-31,Doha ; 2nd International Conference on Food Safety and Regulatory Measures, June 06-08, 2016,London, UK ; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016,Dallas, USA ; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Antonio, USA ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 14: Medicinal Chemistry

Medicinal Chemistry is a branch of chemistry which especially deals with synthetic organic chemistry and pharmacology including various other biological specialties which is involved with design, chemical synthesis and development of drug for marketing of pharmaceutical agents.

Relevant Conferences:

9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 2nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK; ICDDT — 7th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit February 24-25, 2016 Nairobi, Kenya; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 5th RSC / SCI symposium on Ion Channels as Therapeutic Targets March 14-15, 2016 Cambridge, UK ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 15: Traditional Medicine

Traditional medicine is a combination of vast knowledge, skills and practices based on the theories, beliefs and experiences from inherent  to different cultures, whether explicable or not. But used in the maintenance of health as well as in the prevention, diagnosis, treatment of physical and mental illness.

Relevant Conferences:

Global Summit on Herbals & Natural Remedies October 26-27, 2015 Chicago, USA; 2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016 Chicago, USA;  5th International Conference and Exhibition on Traditional & Alternative Medicine September 12-14, Amsterdam, Netherlands; The 2nd Conference on Ethno medicine and Traditional Medicine (CETM 2016) June 1-3, 2016, Nanjing, China; AACMAC 2016-Australasian Acupuncture and Chinese Medicine Annual Conference 20-22 May 2016, Perth, Australia; 10th Australian Homeopathic Medicine Conference, October 22-23, 2016 Brisbane, Australia; Florida Herbal Conference, February 26-28 2016 Florida, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 16: Clinical Studies

Clinical Trial and research studies which tests how well new medical approaches work in people. These studies gives answers for scientific questions and tries to find better ways to eradicate, screen, diagnose or treat a disease. Clinical trials compares a new treatment to a treatment that already exists.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016, Philadelphia ;  1st - 2nd April 2016, Outsourcing in Clinical Trials Europe 2016, May 17-18 2016, France ; 4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ; 6^th Annual American Drug Delivery & Formulation Summit, June 12-14, 2016 | Hilton San Diego Resort & spa, CA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 17: Contract Research Organizations

Organization that give support to the pharmaceutical, biotechnology and medical device Pharmaceutical industries in the form of research services outsourced on a contract basis.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai; 1st - 2nd April 2016, International Conference on Nano medicine, Drug Delivery, and Tissue Engineering , Czech Republic ; 13th - 15th April 2016, 14th European Symposium on Controlled Drug Delivery, Netherlands ; Outsourcing in Clinical Trials Europe 2016, May 17-18 2016, Paris, France ; Promoting Statistical Insight and Collaboration in Drug Development, 22 to 25 May 2016, Berlin ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA  ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 18: Regulatory Requirements

Regulatory affairs are to protect public health by controlling the safety and efficacy of products in pharmaceutical sectors involves medicines and devices. Now a day the increase in the quality of attention in regulatory affairs has created enough challenges to satisfy the strain of health authorities and regulatory agencies. Merely keeping up on changes within the requisites of the markets we need a frenzied team of specialists. The roles and responsibilities typically begin within the analysis and development phases, going in clinical trials and lengthening through premarket approvals, producing, labelling, advertising and post market work best in both Biologics and biotechnology products.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai ; 7th International Conference on Drug Discovery and Therapy,15th -18th February 2016, Dubai, UAE; 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 4-7 April, 2016, Glasgow, UK ;  Society for the Study of Drug Policy ISSDP Conference 2016, 16-18 May, 2016 Sydney Australia ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding Assay; American Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).